Clinical Center; Notice of Meeting, 2177 [05-632]

Download as PDF Federal Register / Vol. 70, No. 8 / Wednesday, January 12, 2005 / Notices 2177 *** The reporting requirements for these sections vary because it is estimated that chimpanzees will be shipped 6 times per year. This requires 6 notifications of shipment to the Project Officer. It is estimated that approximately 1 of these shipments might require reporting because of undesirable conditions such as inadequate food or water, unexpected death or illness, or any conditions affecting animal welfare. Request for Comments: Written comments from the public and affected entities are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper monitoring and oversight of the care, welfare, and maintenance of the chimpanzees, (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) ways to minimize the burden of the collection of the information on those who are to respond, including the use of automated, electronic, mechanical, and other technological collection techniques or other forms of information technology. Direct comments to OMB: Written comments and/or suggestions regarding items contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the Office of Management and Budget, Office of Regulatory Affairs, New Executive Office Building, Room 10235, Washington, DC 20503, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Dr. William Watson, NCRR, 6701 Democracy Boulevard, Room 954, Bethesda, MD 20892–4874, telephone (301) 345–0747 (not a toll-free number), or e-mail; watsonwm@mail.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having full effect if received within 30 days of the date of this publication. Dated: January 11, 2005. Patricia Newman, National Center for Research Services Project Clearance Liaison, National Institutes of Health. [FR Doc. 05–587 Filed 1–11–05; 8:45 am] The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(6), title 5 U.S.C., as amended for discussion of personal qualifications and performance, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: NIH Advisory Board for Clinical Research. Date: January 31, 2005. Open: 2 p.m. to 4 p.m. Agenda: To review the Clinical Center operating plan, ABCR workgroups and Budget update. Place: National Institutes of Health, Building 10, 10 Center Drive, 4–2551, CRC Medical Board Room, Bethesda, MD 20892. Closed: 4 p.m. to 5 p.m. Agenda: For discussion of personal qualifications and performance the disclosure of which constitute a clearly unwarranted invasion of personal privacy. Place: National Institutes of Health, Building 10, 10 Center Drive, 4–2551, CRC Medical Board Room, Bethesda, MD 20892. Contact Person: Maureen E. Gormley, Executive Secretary, Warren Grant Magnuson Clinical Center, National Institutes of Health, Building 10, Room 6–1610, Bethesda, MD 20892, (301) 496–2897, Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Dated: January 6, 2005. Laverne Y, Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–632 Filed 1–11–05; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Naitonal Institutes of Health National Institutes of Health Clinical Center; Notice of Meeting National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the NIH Advisory Board for Clinical Research. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the President’s Cancer Panel. VerDate jul<14>2003 17:37 Jan 11, 2005 Jkt 205001 PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as amended, because the premature disclosure of information and the discussions would likely to significantly frustrate implementation of recommendations. Name of Committee: President’s Cancer Panel. Date: January 18, 2005. Time: 3 p.m. to 5 p.m. Agenda: The Panel will discuss the future focuses of the Panel with direction bearing on prepublication manuscripts on Translating Research into Clinical Practice. These manuscripts have been provided by their authors with the understanding that the Panel will not break prepublicaiton embargo conditions. Place: National Cancer Institute, National Institutes of Health, 31 Center Drive, Building 31, Room 3A18, Bethesda, MD 20892, (Teleconference). Contact Person: Maureen O. Wilson, PhD, Executive Secretary, National Cancer Institute, National Institutes of Health, 31 Center Drive, Building 31, Room 3A18, Bethesda, MD 20892, 301/496–1148. This meeting is being published less than 15 days prior to the meeting due to scheduling conflicts. Any interested person may file written comments with the committee by forwarding the comments to the Contact Person listed on this notice. The comments should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.deainfo.nic.nih.gov/advisory/pcp/ pcp.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research manpower; 93.399, cancer Control, National Institutes of Health, HHS.) Dated: January 5, 2005. Anna P. Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 05–584 Filed 1–11–05; 8:45 am] BILLING CODE 4140–01–M E:\FR\FM\12JAN1.SGM 12JAN1

Agencies

[Federal Register Volume 70, Number 8 (Wednesday, January 12, 2005)]
[Notices]
[Page 2177]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-632]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Clinical Center; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the NIH Advisory Board for Clinical Research.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting. The meeting will be closed to 
the public in accordance with the provisions set forth in section 
552b(c)(6), title 5 U.S.C., as amended for discussion of personal 
qualifications and performance, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: NIH Advisory Board for Clinical Research.
    Date: January 31, 2005.
    Open: 2 p.m. to 4 p.m.
    Agenda: To review the Clinical Center operating plan, ABCR 
workgroups and Budget update.
    Place: National Institutes of Health, Building 10, 10 Center 
Drive, 4-2551, CRC Medical Board Room, Bethesda, MD 20892.
    Closed: 4 p.m. to 5 p.m.
    Agenda: For discussion of personal qualifications and 
performance the disclosure of which constitute a clearly unwarranted 
invasion of personal privacy.
    Place: National Institutes of Health, Building 10, 10 Center 
Drive, 4-2551, CRC Medical Board Room, Bethesda, MD 20892.
    Contact Person: Maureen E. Gormley, Executive Secretary, Warren 
Grant Magnuson Clinical Center, National Institutes of Health, 
Building 10, Room 6-1610, Bethesda, MD 20892, (301) 496-2897,
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

    Dated: January 6, 2005.
Laverne Y, Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-632 Filed 1-11-05; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.